IRS1 and Hypoglycemia: In addition, Lin et al. (2016) demonstrated that entire body transgenic overexpression of miR-155 led to hypoglycemia, improved glucose tolerance and insulin sensitivity, enhanced glycolysis, and insulin-induced AKT and IRS-1 phosphorylation in the liver, adipose tissue, and skeletal muscle.